Emilie Mamessier

13PUBLICATIONS
73CO-AUTHORS
GlycoconjugatesPredictive and prognostic markersMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.

Marc Lopez, Emerence Crompot, Emmanuelle Josselin

|Mar 29, 2023
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype.

Alexandre de Nonneville, Pascal Finetti, Laurys Boudin

|Jan 21, 2023
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma.

David Jeremie Birnbaum, Maelle Picard, Quentin Da Costa

|Oct 25, 2022
Loss of primary cilia promotes inflammation and carcinogenesis.

Conception Paul, Ruizhi Tang, Ciro Longobardi

|Jul 27, 2022
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression.

Laurys Boudin, Alexandre De Nonneville, Pascal Finetti

|May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.

Mathias Neron, Arnaud Guille, Lucie Allegre

Pageof 3

Frequent Collaborators

11 joint publications

François Bertucci

9 joint publications

Pascal Finetti

3 joint publications

Marc Lopez

3 joint publications

Alexandre de Nonneville